Psoriatic Arthritis (PsA)
Clinical Research Study
Not satisfied with your current Psoratic Arthritis treatment?
Local doctors are recruiting participants to enroll in a two period clinical research study on an investigational drug for subjects with active moderate to severe psoriatic arthritis and have inadequate response or intolerance to non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs).
If you or a loved one are over 18 years old, have joints that are swollen and hurting, plaque psoriasis symptoms, and other non-biologic drugs have not worked adequately, you may qualify for this clinical study.
You may qualify for this clinical study if you:
Are 18 years old or older
Have been diagnosed with Psoriatic Arthritis (PsA) with symptoms for at least 6 months
Have a diagnosis of active plaque psoriasis or have documented history of plaque psoriasis
Have inadequate response to previous or current treatment with at least 1 non-biologic DMARD at maximally tolerated dose (MTX, SSZ, LEF, apremilast, bucillamine, cyclosporine, or iguratimod)
Study-related care and medication will be provided at no cost to qualified participants. Qualified participants may be compensated for travel.